glp 1 agonist with dpp 4 inhibitor DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research How do SGLT-2 inhibitors, GLP-1
Description
Tang-Christensen, M
Annals of Internal Medicine
& Ahren, B

Researchers also combined results from different clinical trials with different selection criteria, and only a few participants actually developed cancer

12 These benefits are smaller than the 1520% weight loss observed with GLP-1 RAs or co-agonists
